Identification of Centrosome Duplication‐Related Biomarkers in Hypertrophic Cardiomyopathy Through Integrative Multi‐Omics, Single‐Cell Transcriptomics, and Experimental Validation

Background Hypertrophic cardiomyopathy (HCM) is a prevalent inherited cardiovascular disorder characterized by ventricular wall thickening and myocardial fibrosis. Centrosome duplication‐related gene play critical roles in cell cycle regulation, microtubule organization, and cellular structural homeostasis; however, their mechanistic involvement in HCM remains unclear. Methods An integrative multi‐omics strategy was used, incorporating differential expression analysis, weighted gene co‐expression network analysis, Mendelian randomization), and multiple machine‐learning models to identify centrosome duplication‐related genes associated with HCM. Single‐cell RNA sequencing was used to assess cell‐type‐specific expression patterns, followed by in vitro functional assays in cardiomyocytes. Results Two candidate biomarkers, HBEGF and VPS8 , were significantly associated with HCM across multiple data sets. Single‐cell transcriptomic analysis revealed high VPS8 expression in cardiomyocytes and dendritic cells. Functional assays show that VPS8 knockdown suppressed cardiomyocyte proliferation, increased apoptosis, and reduced the expression of proteins involved in centrosome and microtubule organization, suggesting its involvement in structural maintenance and cell cycle regulation. Conclusions This study suggests a potential association between centrosome duplication‐related gene dysregulation and HCM pathogenesis and identifies VPS8 as a key regulator bridging endosomal–lysosomal homeostasis and immune‐related remodeling. VPS8 may represent a candidate biomarker and a potential therapeutic target for early diagnosis and intervention in HCM.